Követés
Povilas Norvaišas
Povilas Norvaišas
Ro5
E-mail megerősítve itt: ro5.ai
Cím
Hivatkozott rá
Hivatkozott rá
Év
Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans
TA Scott, LM Quintaneiro, P Norvaisas, PP Lui, MP Wilson, KY Leung, ...
Cell 169 (3), 442-456. e18, 2017
2352017
Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy
R Pryor, P Norvaisas, G Marinos, L Best, LB Thingholm, LM Quintaneiro, ...
Cell 178 (6), 1299-1312. e29, 2019
1942019
Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX
V Dudutiene, J Matuliene, A Smirnov, DD Timm, A Zubriene, ...
Journal of Medicinal Chemistry 57 (22), 9435-9446, 2014
912014
Intrinsic thermodynamics of 4-substituted-2, 3, 5, 6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry
A Zubrienė, J Smirnovienė, A Smirnov, V Morkūnaitė, V Michailovienė, ...
Biophysical Chemistry 205, 51-65, 2015
602015
Fine-tuning autophagy maximises lifespan and is associated with changes in mitochondrial gene expression in Drosophila
I Bjedov, HM Cochemé, A Foley, D Wieser, NS Woodling, JI Castillo-Quan, ...
PLoS genetics 16 (11), e1009083, 2020
502020
Thermodynamics of cationic and anionic surfactant interaction
P Norvaišas, V Petrauskas, D Matulis
The Journal of Physical Chemistry B 116 (7), 2138-2144, 2012
372012
The role of payload hydrophobicity in nanotherapeutic pharmacokinetics
P Norvaisas, A Ziemys
Journal of pharmaceutical sciences 103 (7), 2147-2156, 2014
222014
WormJam: A consensus C. elegans Metabolic Reconstruction and Metabolomics Community and Workshop Series
J Hastings, A Mains, M Artal-Sanz, S Bergmann, BP Braeckman, J Bundy, ...
Worm 6 (2), e1373939, 2017
172017
Revisiting Santa Rosalia to unfold a degeneracy of classic models of speciation
P Norvaišas, E Kisdi
The American Naturalist 180 (3), 388-393, 2012
142012
High pressure spectrofluorimetry–a tool to determine protein-ligand binding volume
G Skvarnavičius, Z Toleikis, M Grigaliūnas, J Smirnovienė, P Norvaišas, ...
Journal of Physics: Conference Series 950 (4), 042001, 2017
92017
Pharmacology in the age of the holobiont
P Norvaisas, F Cabreiro
Current Opinion in Systems Biology 10, 34-42, 2018
72018
Hydrascreen: A generalizable structure-based deep learning approach to drug discovery
A Prat, HA Aty, G Kamuntavičius, T Paquet, P Norvaišas, P Gasparotto, ...
arXiv preprint arXiv:2311.12814, 2023
22023
The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs
P Norvaisas, D Chan, K Yokoi, B Dave, A Ziemys
European Journal of Cancer Prevention 25 (1), 77-84, 2016
22016
Prediction and analysis of drug delivery systems: from drug-vector compatibility to release kinetics
P Norvaisas, M Kojic, M Milosevic, A Ziemys
Scientifically speaking September, 14-15, 2013
22013
Benchmarking ML in ADMET predictions: the practical impact of feature representations in ligand-based models
G Kamuntavičius, T Paquet, O Bastas, P Norvaišas, R Tal
2024
Benchmarking ML in ADMET predictions: A focus on hypothesis testing practices
G Kamuntavičius, O Bastas, T Paquet, P Norvaišas, R Tal
2024
Accelerated Hit Identification with Target Evaluation, Deep Learning and Automated Labs: Prospective Validation in IRAK1
G Kamuntavičius, A Prat, T Paquet, O Bastas, HA Aty, Q Sun, ...
2024
Prospective Validation of HydraScreen: Virtual Screening and Hit Identification in IRAK1
G Kamuntavičius, A Prat, T Paquet, O Bastas, HA Aty, Q Sun, D Rines, ...
2023
System and method for feedback-driven automated drug discovery
P Norvaisas, R Tal, Z Jocys, CD Knuff, A Prat, G Kamuntavicius, HA Aty, ...
US Patent App. 17/845,813, 2022
2022
Discovery of a Novel Allosteric Inhibitor PK-188 Targeting New Delhi Metallo-β Lactamases.
P Kavaliauskas, D Tondi, L Cendron, B Grybaite, K Anusevicius, ...
32nd European Congress of Clinical Microbiology and Infectious Diseases., 2022
2022
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20